4.2 Article

The gastrointestinal microbiome - Functional interference between stomach and intestine

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2014.10.004

关键词

Gastric microbiota; Gut microbiota; Helicobacter pylori; Clostridia; Gastric intestinal interference; Gastric modulation of Gut microbiota

向作者/读者索取更多资源

The gastrointestinal (GI) tract is a complex and dynamic network with interplay between various gut mucosal cells and their defence molecules, the immune system, food particles, and the resident microbiota. This ecosystem acts as a functional unit organized as a semipermeable multi-layer system that allows the absorption of nutrients and macromolecules required for human metabolic processes and, on the other hand, protects the individual from potentially invasive microorganisms. Commensal microbiota and the host are a unique entity in a continuum along the GI tract, every change in one of these players is able to modify the whole homeostasis. In the stomach, Helicobacter pylori is a gram-negative pathogen that is widespread all over the world, infecting more than 50% of the world's population. In this scenario, H. pylori infection is associated with changes in the gastric microenvironment, which in turn affects the gastric microbiota composition, but also might trigger large intestinal microbiota changes. It is able to influence all the vital pathways of human system and also to influence microbiota composition along the GI tract. This can cause a change in the normal functions exerted by intestinal commensal microorganisms leading to a new gastrointestinal physiological balance. This review focuses and speculates on the possible interactions between gastric microorganisms and intestinal microbiota and on the consequences of this interplay in modulating gut health. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

The role of diet in shaping human gut microbiota

Emanuele Rinninella, Ege Tohumcu, Pauline Raoul, Marcello Fiorani, Marco Cintoni, Maria Cristina Mele, Giovanni Cammarota, Antonio Gasbarrini, Gianluca Ianiro

Summary: Gut microbiota plays a crucial role in human health and has significant impacts on the body. Diet has a powerful influence on the functions and composition of gut microbiota, involving the immune system and the intestinal barrier. In this review article, we discuss the effects of specific dietary nutrients and patterns on the composition of human gut microbiota, as well as the potential application of diet as a therapeutic modulator for gut microbiota.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2023)

Article Cardiac & Cardiovascular Systems

Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

Elisabetta Nardella, Federico Biscetti, Maria Margherita Rando, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Enrica Rossini, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex

Summary: This study aimed to investigate the relationship between a panel of biomarkers and the risk of cardiovascular events and limb events after lower-extremity endovascular revascularization in diabetic patients with chronic limb threatening ischemia (CLTI). Elevated levels of IL-1, IL-6, CRP, TNF-alpha, HMGB-1, OPG, and Sortilin, and low levels of Omentin-1 at baseline were found to be associated with worse vascular outcomes. Assessing the inflammatory state with this panel of biomarkers may help identify patients at higher risk of procedure failure and cardiovascular adverse events after revascularization.

CARDIOVASCULAR DIABETOLOGY (2023)

Review Gastroenterology & Hepatology

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties

Giuseppe Marrone, Amato Serra, Luca Miele, Marco Biolato, Antonio Liguori, Antonio Grieco, Antonio Gasbarrini

Summary: Liver cirrhosis is often accompanied by nutritional alterations, affecting about 20% of patients with compensated disease and over 60% of patients with decompensated cirrhosis. Imbalance of amino acids, especially branched-chain amino acids (BCAAs), has been shown to be associated with complications and prognosis in these patients. Various studies have explored the use of BCAAs supplementation as a therapeutic option, but uncertainties persist regarding its real efficacy, optimal administration route, and dosage.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Review Nutrition & Dietetics

The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights

Giuseppe Marano, Marianna Mazza, Francesco Maria Lisci, Michele Ciliberto, Gianandrea Traversi, Georgios Demetrios Kotzalidis, Domenico De Berardis, Lucrezia Laterza, Gabriele Sani, Antonio Gasbarrini, Eleonora Gaetani

Summary: There is increasing interest in the role of intestinal microbiota and autoimmune processes in psychiatric diseases. Altered communication between the microbiota-gut-brain axis may be a cause of psychiatric disorders. This review explores the evidence for the involvement of gut microbiota in psychiatric diseases and the impact of diet on microbiota and mental health. Changes in gut microbiota composition can lead to increased intestinal permeability, resulting in a cytokine storm, systemic inflammation, and immune response. These events can affect neurotransmitter release, alter the hypothalamic-pituitary-adrenal axis, and reduce trophic brain factors. Further research is needed to understand the underlying mechanisms connecting gut microbiota and psychiatric disorders.

NUTRIENTS (2023)

Article Allergy

Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis

Cristiano Caruso, Stefania Colantuono, Barbara Tolusso, Clara Di Mario, Giovanni Fancello, Marilena La Sorda, Giorgio Celi, Mario Caringi, Anna Volterrani, Desideria Descalzi, Elisa Gremese, Maurizio Sanguinetti, Antonio Gasbarrini

Summary: This study aimed to find biomarkers that can monitor or predict the effectiveness of allergen immunotherapy (AIT). The results showed that both clinical and laboratory biomarkers can be used to monitor AIT effectiveness. Economic analysis also confirmed the positive impact of immunotherapy.

WORLD ALLERGY ORGANIZATION JOURNAL (2023)

Review Oncology

The Role of Microbiota in Pancreatic Cancer

Valerio Papa, Tommaso Schepis, Gaetano Coppola, Michele Francesco Chiappetta, Livio Enrico Del Vecchio, Tommaso Rozera, Giuseppe Quero, Antonio Gasbarrini, Sergio Alfieri, Alfredo Papa

Summary: Pancreatic cancer is a difficult-to-treat disease, and exploring the role of microbiota in its development and treatment holds promise for improving outcomes. The gut, pancreatic, and oral microbiota have been shown to play a role in the pathogenesis of pancreatic cancer, and changes in these microbiota can potentially be used for early diagnosis and predicting treatment response. Further research is needed to increase the available data in this promising area.

CANCERS (2023)

Article Infectious Diseases

Reduced Prognostic Role of Serum PCT Measurement in Very Frail Older Adults Admitted to the Emergency Department

Andrea Russo, Sara Salini, Giordana Gava, Giuseppe Merra, Andrea Piccioni, Giuseppe De Matteis, Gianluca Tullo, Angela Novelli, Martina Petrucci, Antonio Gasbarrini, Francesco Landi, Francesco Franceschi, Marcello Covino

Summary: This study evaluates the prognostic role of serum PCT in older patients with suspect sepsis or infective diagnosis in the Emergency Department, with a focus on frailty status. The results show that PCT values at ED admission do not predict infective diagnosis or higher odds of in-hospital death. However, in frail older adults, PCT values in ED can be a useful predictor of bloodstream infection.

ANTIBIOTICS-BASEL (2023)

Review Infectious Diseases

Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders

Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito

Summary: The gut microbiota plays a crucial role in maintaining the balance in the hepato-biliary-pancreatic system, with metabolic and immunologic functions that influence the homeostasis of the whole organism and the pathogenesis of various diseases. Chronic liver disease and pancreatic disorders can cause imbalances in gut microbiota, leading to harmful consequences for the host's health. The modulation of gut microbiota through antibiotics represents a pioneering challenge with potential therapeutic opportunities, even for non-infectious diseases.

ANTIBIOTICS-BASEL (2023)

Review Health Care Sciences & Services

Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness

Matteo Garcovich, Mattia Paratore, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco

Summary: The development of new applications in ultrasound imaging, especially elastography techniques, have strengthened the role of ultrasound in the management of liver disease. Among the new elastography techniques, shear wave dispersion has the potential to provide information about the viscosity of liver tissue and the pathologic state of the liver. Recent ultrasound devices have been embedded with software to evaluate shear wave dispersion/liver viscosity. This review discusses the feasibility and clinical applications of liver viscosity based on preliminary findings from animal and human studies.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Review Gastroenterology & Hepatology

Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach

Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso

Summary: Immune-related adverse events (IRAEs) are a significant side effect arising from the use of immune checkpoint inhibitors (ICIs), with checkpoint inhibitor colitis being the most widely reported IRAE. This review comprehensively discusses the current evidence regarding the pathogenesis, diagnosis, and management of ICIs-induced colitis, including innovative therapies.

INFLAMMATORY BOWEL DISEASES (2023)

Article Gastroenterology & Hepatology

Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts

Giuseppe Marrone, Marcello Covino, Giuseppe Merra, Andrea Piccioni, Annamaria Amodeo, Angela Novelli, Rita Murri, Maurizio Pompili, Antonio Gasbarrini, Francesco Franceschi

Summary: This retrospective study evaluated the clinical course and outcome of COVID-19 patients treated with UDCA and found that UDCA treatment does not have a significant effect on the outcome of COVID-19. Further prospective studies are needed to evaluate its efficacy in preventing infection and severe disease.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection

Filippo Pelizzaro, Franco Trevisani, Vittorio Simeon, Alessandro Vitale, Umberto Cillo, Fabio Piscaglia, Gabriele Missale, Angelo Sangiovanni, Francesco G. Foschi, Giuseppe Cabibbo, Eugenio Caturelli, Maria Di Marco, Francesco Azzaroli, Maurizia R. Brunetto, Giovanni Raimondo, Gianpaolo Vidili, Maria Guarino, Antonio Gasbarrini, Claudia Campani, Gianluca Svegliati-Baroni, Edoardo G. Giannini, Andrea Mega, Alberto Masotto, Gian Ludovico Rapaccini, Donatella Magalotti, Rodolfo Sacco, Gerardo Nardone, Fabio Farinati

Summary: This study evaluated the incidence and predictors of non-transplantable recurrence in patients with single hepatocellular carcinoma (HCC) <= 5 cm treated with liver resection (LR). The results showed that HCC size >= 4 cm and high alpha-fetoprotein (AFP) level at the time of LR were independent predictors of recurrence beyond established criteria. Microvascular invasion and microsatellite lesions were identified as additional independent risk factors for non-transplantable recurrence.

LIVER INTERNATIONAL (2023)

Article Infectious Diseases

Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013-2022: Data from the European Registry on H. pylori Management (Hp-EuReg)

Olga. P. Nyssen, Pietro Pratesi, Miguel. A. Spinola, Laimas Jonaitis, Angeles Perez-Aisa, Dino Vaira, Ilaria Maria Saracino, Matteo Pavoni, Giulia Fiorini, Bojan Tepes, Dmitry. S. Bordin, Irina Voynovan, Angel Lanas, Samuel. J. Martinez-Dominguez, Enrique Alfaro, Luis Bujanda, Manuel Pabon-Carrasco, Luis Hernandez, Antonio Gasbarrini, Juozas Kupcinskas, Frode Lerang, Sinead. M. Smith, Oleksiy Gridnyev, Marcis Leja, Theodore Rokkas, Ricardo Marcos-Pinto, Antonio Mestrovic, Wojciech Marlicz, Vladimir Milivojevic, Halis Simsek, Lumir Kunovsky, Veronika Papp, Perminder. S. Phull, Marino Venerito, Lyudmila Boyanova, Doron Boltin, Yaron Niv, Tamara Matysiak-Budnik, Michael Doulberis, Daniela Dobru, Vincent Lamy, Lisette. G. Capelle, Emilijia Nikolovska Trpchevska, Leticia Moreira, Anna Cano-Catalia, Pablo Parra, Francis Megraud, Colm O'Morain, Guillermo. J. Ortega, Javier. P. Gisbert

Summary: The segmentation of patients into homogeneous groups can improve the effectiveness of eradication therapy. The study aims to determine the most important treatment strategies used in Europe and evaluate the effectiveness of first-line treatments based on year and country. The analysis found that the overall treatment effectiveness increased from 87% in 2013 to 93% in 2022, with the highest effectiveness achieved in 2022 using bismuth-quadruple therapy in Spain. Cluster analysis identified homogeneous treatment groups and assessed the effectiveness of different first-line treatments.

ANTIBIOTICS-BASEL (2023)

Review Cell Biology

Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity

Vincenzo Giambra, Danilo Pagliari, Pierluigi Rio, Beatrice Totti, Chiara Di Nunzio, Annalisa Bosi, Cristina Giaroni, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci

Summary: Inflammatory bowel diseases (IBDs) are characterized by chronic inflammation and an increased risk of colorectal cancer (CRC) development. The imbalance between the immune system and gut microbiota leads to changes in gut permeability, triggering inflammatory responses. This review provides an overview of pattern recognition receptors (PRRs), including their recognition mechanisms, signaling pathways, and contributions to immune responses.
Review Biochemistry & Molecular Biology

Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation

Andrea Leonardo Cecchini, Federico Biscetti, Matteo Manzato, Lorenzo Lo Sasso, Maria Margherita Rando, Maria Anna Nicolazzi, Enrica Rossini, Luis H. Eraso, Paul J. Dimuzio, Massimo Massetti, Antonio Gasbarrini, Andrea Flex

Summary: This paper provides a literature review on pharmacotherapy for peripheral artery disease (PAD), focusing on the effects of different drug classes on inflammatory pathways. The study found that current treatments have anti-inflammatory properties that can potentially delay or prevent progression of PAD and improve outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据